Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors

Date Added
March 24th, 2022
PRO Number
Pro00119817
Researcher
William Lancaster

List of Studies


Keywords
Cancer/Gastrointestinal, Pancreas
Summary

This study is for patients who have had surgery for pancreatic neuroendocrine tumor (pNET). This study is being done to find out if giving chemotherapy after surgery is better or worse than the usual approach for patients that have had surgery for pNET.

Institution
MUSC
Recruitment Contact
HCC Clinical Trials Office
(843) 792-9321
hcc-clinical-trials@musc.edu

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs

Date Added
January 27th, 2022
PRO Number
Pro00117978
Researcher
Albert Lockhart

List of Studies

Keywords
Pancreas
Summary

This study is for people with pancreatic cysts. This study is being done to see
which approach, less frequent monitoring or more frequent monitoring, will lead to better outcomes.

Institution
MUSC
Recruitment Contact
Barbara Roe
843-652-1607
Broe@tidelandshealth.org

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Evinacumab in Patients with Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis

Date Added
January 25th, 2022
PRO Number
Pro00117821
Researcher
James Thomas

List of Studies


Keywords
Cholesterol, Pancreas
Summary

Research study looking for participants with have severe hypertriglyceridemia (elevated fat levels in the blood), which may increase the risk for pancreatitis (inflammation of the pancreas). The study is being carried out to see if a new investigational drug called Evinacumab (human IgG4 monoclonal antibody) decreases the risks of future Recurrent Acute Pancreatitis episodes when given the medication every 4 weeks by infusion for 12 months and follow up visits at 1 and 2 months after your last dose. There will also be 2 follow up telephone calls, so that the total duration you are in the study will be approximately 2 years.

Institution
MUSC
Recruitment Contact
Della MacNicholas
843-876-5012
macnichd@musc.edu